Erratum to: Neonatal Junctional Epidermolysis Bullosa: Treatment Conundrums and Ethical Decision Making (Am J Clin Dermatol, (2014), 15, (445–450), DOI 10.1007/s40257-014-0091-7);Neonatal Junctional Epidermolysis Bullosa: Treatment Conundrums and Ethical Decision Making

American Journal of Clinical Dermatology

Volumn 15, Issue 5, 2014, Pages 445-450

  Yang, Catherine S ^a   Kroshinksy, Daniela ^b   Cummings, Brian M ^b  

^a BROWN UNIVERSITY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFEPIME; FLUCONAZOLE; KALININ; LAMININ; LAMININ BETA3; METHADONE; MIDAZOLAM; MORPHINE; UNCLASSIFIED DRUG; VANCOMYCIN; ZINC;

ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; BACTERIAL GROWTH; BLISTER; BLOOD CULTURE; BODY TEMPERATURE; BRADYCARDIA; CALORIC INTAKE; CANDIDA PARAPSILOSIS; CASE REPORT; EPIDERMOLYSIS BULLOSA; EROSION; ETHICAL DECISION MAKING; FAILURE TO THRIVE; FINGER NAIL; FRAMESHIFT MUTATION; FUNGUS GROWTH; GENE INSERTION; GENETIC SCREENING; GROWTH CURVE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IRON DEFICIENCY ANEMIA; LUNG FUNCTION TEST; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NAIL DYSTROPHY; NEONATAL JUNCTIONAL EPIDERMOLYSIS BULLOSA; NEWBORN; NEWBORN DEATH; NEWBORN DISEASE; NEWBORN SEPSIS; NONSENSE MUTATION; NUTRITIONAL DISORDER; NUTRITIONAL STATUS; PROTEIN LOSING GASTROENTEROPATHY; PSEUDOMONAS AERUGINOSA; RECURRENT INFECTION; REVIEW; SKIN BIOPSY; STOMACH TUBE; STRIDOR; TOTAL PARENTERAL NUTRITION; TRANSMISSION ELECTRON MICROSCOPY; WEIGHT GAIN; WOUND CARE; DECISION MAKING; EPIDERMOLYSIS BULLOSA, JUNCTIONAL; ETHICS; FUNGEMIA; INFANT; MORTALITY; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

CHILD, PRESCHOOL; DECISION MAKING; EPIDERMOLYSIS BULLOSA, JUNCTIONAL; FUNGEMIA; HUMANS; INFANT; INFANT, NEWBORN; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 84918798644     PISSN: 11750561     EISSN: 11791888     Source Type: Journal    
DOI: 10.1007/s40257-016-0188-2     Document Type: Erratum

References (43)

1. Fine JD, Bruckner-Tuderman L, Eady RAJ, et al. Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification. J Am Acad Dermatol. 2014;70:1103–26.
2. Fine JD, Johnson LB, Suchindran C, et al. The epidemiology of inherited epidermolysis bullosa. Findings in U.S., Canadian, and European study populations. In: Fine JD, Bauer EA, McGuire J, Moshell A, editors. Epidermolysis bullosa: clinical, epidemiologic, and laboratory advances and the findings of the National Epidermolysis Bullosa Registry. Baltimore: Johns Hopkins University Press; 1999. p. 101–13.
3. Castori M, Floriddia G, De Luca N, et al. Herlitz junctional epidermolysis bullosa: laminin-5 mutational profile and carrier frequency in the Italian population. Br J Dermatol. 2008;158:38–44.
4. Yuen WY, Lemmink HH, van Dijk-Bos KK, et al. Herlitz junctional epidermolysis bullosa: diagnostic features, mutational profile, incidence and population carrier frequency in the Netherlands. Br J Dermatol. 2011;165:1314–22.
5. Kelly-Mancuso G, Kopelan B, Azizkhan RG, et al. Junctional epidermolysis bullosa incidence and survival: 5-year experience of the Dystrophic Epidermolysis Bullosa Research Association of America (DebRA) nurse educator, 2007 to 2011. Pediatr Dermatol. 2014;31:159–62.
6. Yuen WY, Duipmans JC, Molenbuur B, et al. Long-term follow-up of patients with Herlitz-type junctional epidermolysis bullosa. Br J Dermatol. 2012;167:374–82.
7. Nischler E, Klausegger A, Hüttner C, et al. Diagnostic pitfalls in newborns and babies with blisters and erosions. Dermatol Res Pract. 2009;2009:320403.
8. Berk DR, Jazayeri L, Marinkovich MP, et al. Diagnosing epidermolysis bullosa type and subtype in infancy using immunofluorescence microscopy: the Stanford experience. Pediatr Dermatol. 2013;30:226–33.
9. Yiasemides E, Walton J, Marr P, et al. A comparative study between transmission electron microscopy and immunofluorescence mapping in the diagnosis of epidermolysis bullosa. Am J Dermatopathol. 2006;28:387–94.
10. Salas-Alanis JC, Cepeda-Valdes R, Mellerio JE, et al. Progress in epidermolysis bullosa: summary of a workshop in CILAD-2010. Int J Dermatol. 2012;51:682–7.
11. Mellerio JE. Infection and colonization in epidermolysis bullosa. Dermatol Clin. 2010;28:267–269 ix.
12. Gonzalez ME. Evaluation and treatment of the newborn with epidermolysis bullosa. Semin Perinatol. 2013;37:32–9.
13. Freeman EB, Köglmeier J, Martinez AE, et al. Gastrointestinal complications of epidermolysis bullosa in children. Br J Dermatol. 2008;158:1308–14.
14. Fine JD, Mellerio JE. Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part I. Epithelial associated tissues. J Am Acad Dermatol. 2009;61:367–84.
15. Gamelli RL. Nutritional problems of the acute and chronic burn patient. Relevance to epidermolysis bullosa. Arch Dermatol. 1988;124:756–9.
16. Hubbard L, Haynes L, Sklar M, et al. The challenges of meeting nutritional requirements in children and adults with epidermolysis bullosa: proceedings of a multidisciplinary team study day. Clin Exp Dermatol. 2011;36:579–83.
17. Haynes L, Mellerio JE, Martinez AE. Gastrostomy tube feeding in children with epidermolysis bullosa: consideration of key issues. Pediatr Dermatol. 2012;29:277–84.
18. Goldschneider K, Lucky AW, Mellerio JE, et al. Perioperative care of patients with epidermolysis bullosa: proceedings of the 5th international symposium on epidermolysis bullosa, Santiago Chile, December 4–6, 2008. Paediatr Anaesth. 2010;20:797–804.
19. Marra AR, Opilla M, Edmond MB, et al. Epidemiology of bloodstream infections in patients receiving long-term total parenteral nutrition. J Clin Gastroenterol. 2007;41:19–28.
20. Kho YC, Rhodes LM, Robertson SJ, et al. Epidemiology of epidermolysis bullosa in the antipodes: the Australasian Epidermolysis Bullosa Registry with a focus on Herlitz junctional epidermolysis bullosa. Arch Dermatol. 2010;146:635–40.
21. Fine JD, Johnson LB, Weiner M, et al. Tracheolaryngeal complications of inherited epidermolysis bullosa: cumulative experience of the national epidermolysis bullosa registry. Laryngoscope. 2007;117:1652–60.
22. Hore I, Bajaj Y, Denyer J, et al. The management of general and disease specific ENT problems in children with epidermolysis bullosa—a retrospective case note review. Int J Pediatr Otorhinolaryngol. 2007;71:385–91.
23. Fine JD. Squamous cell carcinoma and junctional epidermolysis bullosa [letter]. J Am Acad Dermatol. 2012;66:856–7.
24. Yuen WY, Jonkman MF. Reply [letter]. J Am Acad Dermatol. 2012;66:857–8.
25. Yan EG, Paris JJ, Ahluwalia J, et al. Treatment decision-making for patients with the Herlitz subtype of junctional epidermolysis bullosa. J Perinatol. 2007;27:307–11.
26. Schneiderman LJ. Medical futility: response to critiques. Ann Intern Med. 1996;125:669.
27. Schneiderman LJ, Jecker NS, Jonsen AR. Medical futility: its meaning and ethical implications. Ann Intern Med. 1990;112:949–54.
28. Fine JD, Johnson LB, Weiner M, et al. Cause-specific risks of childhood death in inherited epidermolysis bullosa. J Pediatr. 2008;152:276–80.
29. Committee on Bioethics. Guidelines on forgoing life-sustaining medical treatment. Pediatrics. 1994;93:532–6.
30. Diekema DS, Botkin JR. Clinical report—forgoing medically provided nutrition and hydration in children. Pediatrics. 2009;124:813–22.
31. Verhagen AAE, van der Hoeven MAH, van Meerveld RC, et al. Physician medical decision-making at the end of life in newborns: insight into implementation at 2 Dutch centers. Pediatrics. 2007;120:e20–8.
32. Verhagen E, Sauer PJJ. The Groningen protocol—euthanasia in severely ill newborns. N Engl J Med. 2005;352:959–62.
33. Verhagen AAE, Sauer PJJ. End-of-life decisions in newborns: an approach from The Netherlands. Pediatrics. 2005;116:736–9.
34. Verhagen AAE. The Groningen Protocol for newborn euthanasia; which way did the slippery slope tilt? J Med Ethics. 2013;39:293–5.
35. Yuen WY, Duipmans JC, Jonkman MF. The needs of parents with children suffering from lethal epidermolysis bullosa. Br J Dermatol. 2012;167:613–8.
36. Verhagen AAE, Janvier A, Leuthner SR, et al. Categorizing neonatal deaths: a cross-cultural study in the United States, Canada, and The Netherlands. J Pediatr. 2010;156:33–7.
37. Kon AA. We cannot accurately predict the extent of an infant’s future suffering: the Groningen Protocol is too dangerous to support. Am J Bioeth. 2008;8:27–9.
38. Kodish E. Paediatric ethics: a repudiation of the Groningen protocol. Lancet. 2008;371:892–3.
39. Gostyński A, Pasmooij AMG, Jonkman MF. Successful therapeutic transplantation of revertant skin in epidermolysis bullosa. J Am Acad Dermatol. 2014;70:98–101.
40. Pasmooij AMG, Nijenhuis M, Brander R, et al. Natural gene therapy may occur in all patients with generalized non-Herlitz junctional epidermolysis bullosa with COL17A1 mutations. J Invest Dermatol. 2012;132:1374–83.
41. Mavilio F, Pellegrini G, Ferrari S, et al. Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nat Med. 2006;12:1397–402.
42. Wagner JE, Ishida-Yamamoto A, McGrath JA, et al. Bone marrow transplantation for recessive dystrophic epidermolysis bullosa. N Engl J Med. 2010;363:629–39.
43. Tolar J, Wagner JE. Management of severe epidermolysis bullosa by haematopoietic transplant: principles, perspectives and pitfalls. Exp Dermatol. 2012;21:896–900.